Journal of Drug Design and Development-Lupine Publishers

Would Hydroxychloroquine Be A New PromisingDrug in Managing Antiphospholipid Syndrome?

by Amani Mohsen in DDIPIJ in Lupine Publishers.

Once Antiphospholipid syndrome (APS) is diagnosed, risk profile of the patient will impact its management whether there was a previous thrombotic event or not, association with other autoimmune disorders, presence of other obstetrical complications as well as being currently pregnant. The current recommended regimen for preventing obstetrical complications. The current recommended regimen for preventing obstetrical complications includes low molecular weight Heparin and low dose aspirin. This regimen decreases the risk of miscarriage by only 54%. Here, we will review the studies that evaluated adding Hydroxychloroquine (HCQ) to the treatment of APS and how effective it would be.To know more click on below link.

https://lupinepublishers.com/drug-designing-journal/fulltext/would-hydroxychloroquine-be-a-new-promising-drug-in-managing-antiphospholipid-syndrome.ID.000141.php

For more Lupine Publishers Open Access Journals Please visit our website: http://www.lupinepublishers.com/

For more Journal of Drug Design and Development articles Please Click Here: https://lupinepublishers.com/drug-designing-journal/